It is well established that EMT is involved in acquired drug resistance to EGFR-TKIs in NSCLC cells carrying wild-type EGFR, for instance, in A549 [8, 30] and in H1229 cells [30]. Here, EGFR is linked to non-small cell lung carcinoma.